Self‐Propelled In Situ Polymerized Nanoparticles Activating the STING Pathway for Enhanced Bladder Cancer Immunotherapy
Open Access
- 26 March 2025
- journal article
- Published by Wiley in Advanced Science
- Vol. 12 (25) , e2502750
Abstract
Bladder cancer, a common malignancy of the urinary tract, presents complex therapeutic challenges, thereby necessitating the exploration of innovative treatment strategies. This study introduces a novel, self‐propelled nanomedicine delivery system that forms nanoparticles within the bladder lumen by co‐infusing dopamine hydrochloride, Mn 2+ , cGAMP, and urease into the bladder to initiate in situ polymerization. The resulting Mn‐cGAMP@PDA‐urease (DMCU) nanoparticles possess a urease‐modified surface, which acts as an engine to generate propulsive force by breaking down urea. Consequently, this process enhances nanoparticle retention in the bladder mucosa and facilitates efficient drug delivery. The self‐assembled nanoparticles activate the STING pathway, promoting dendritic cell maturation and activation of T cells, thereby enhancing anti‐tumor immune responses. These nanoparticles remain in the bladder for an extended period, significantly improving therapeutic efficacy by sustaining drug release and reducing adverse side effects. In vivo, experiments using a mouse orthotopic model of bladder cancer demonstrate that the DMCU system enhances tumor suppression and immune activation compared with conventional therapies. This novel approach integrates nanotechnology with immunomodulation to address chemotherapy resistance and improve therapeutic efficacy.Keywords
Funding Information
- National Natural Science Foundation of China (82102171, 62425112, 92359202, 12326610)
- Science, Technology and Innovation Commission of Shenzhen Municipality (RCJC20200714114557005)
- Shenzhen Science and Technology Innovation Program (JCYJ20230807141009020)
This publication has 32 references indexed in Scilit:
- Single-cell transcriptome analysis reveals the association between histone lactylation and cisplatin resistance in bladder cancerDrug Resistance Updates, 2024
- An Ellagic Acid Coordinated Copper‐Based Nanoplatform for Efficiently Overcoming Cancer Chemoresistance by Cuproptosis and Synergistic Inhibition of Cancer Cell StemnessSmall, 2023
- Targeting DNA Damage and Repair Machinery via Delivering WEE1 Inhibitor and Platinum (IV) Prodrugs to Stimulate STING Pathway for Maximizing Chemo‐Immunotherapy in Bladder CancerAdvanced Materials, 2023
- Chemotactic Micro/Nanomotors for Biomedical ApplicationsSmall, 2023
- Achieving Control in Micro‐/Nanomotor MobilityAngewandte Chemie International Edition, 2022
- Reduction Sensitive Polymers Delivering Cationic Platinum Drugs as STING Agonists for Enhanced Chemo‐ImmunotherapyAdvanced Functional Materials, 2022
- Engineering Radiosensitizer‐Based Metal‐Phenolic Networks Potentiate STING Pathway Activation for Advanced RadiotherapyAdvanced Materials, 2021
- Bladder CancerJAMA, 2020
- Self‐Propelled Micro/Nanomotors for Tumor Targeting Delivery and TherapyAdvanced Healthcare Materials, 2020
- In Situ Polymerization of Dopamine on Graphene Framework for Charge Storage ApplicationsSmall, 2018